ASH 2011 Conference Coverage

Farydak (panobinostat) now FDA-approved for multiple myeloma

Drug is now sanctioned for people who have received at least two prior standard therapies.

Patients with detectable PSA after prostatectomy should receive more aggressive radiation therapy

Prostate cancer patients with detectable prostate specific antigen (PSA) following radical prostatectomy are advised to receive more aggressive radiation therapy treatment, according to a study.

Increase in brain tumors is not attributed to mobile phone use

Brain cancer is not increased by mobile phone use.

Black men have lower preference for investigation of prostate cancer

Black men are less willing to be investigated for prostate cancer, thereby increasing the likelihood of being diagnosed.

ASCO: Active surveillance for prostate cancer may decrease survival odds for some

When active surveillance is chosen, survival for intermediate-risk disease may be decreased.

Aluminum-containing deodorant safe for patients with breast cancer undergoing radiotherapy

Women undergoing radiotherapy for breast cancer can use deodorant without increasing risk of underarm skin reactions, pain, itching, or burning.

Finding a qualified acupuncture practitioner

How can patients find a qualified acupuncture practitioner who understands the needs of oncology patients?

Suicide deemed public health concern in those with genitourinary cancers

Risk factors for suicide include male gender, distant disease, increasing age, race/ethnicity.

New opportunity to treat drug-resistant leukemia discovered

A previously unrecognized action as a potent inhibitor of the dominant mutation that confers drug resistance to all well-tolerated treatments in patients with certain leukemia types has been found in Axitinib.

Major study links two new genetic variants to breast cancer

A worldwide study of the DNA of 100,000 women has discovered two new genetic variants associated with an increased risk of breast cancer.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs